Oral administration
Sponsors
Basilea Pharmaceutica International AG Allschwil, Yamamoto Noboru, Nagao Kiminori, Namiki Takao, Yamaguchi Daisuke
Conditions
AnesthesiaCOVID-19
Respiratory Tract InfectionsCandidemiaChronic EndometritisHealthy subjectsInvasive candidiasisMicroecological TherapyPatients with Unresectable advanced or recurrent solid tumors
Solid tumor
Early Phase 1
Phase 1
Phase 2
Εffectiveness of Intrauterine Antibiotic Administration for Treatment of Chronic Endometritis
NCT05205993
Start: 2021-01-19End: 2024-04-30Target: 90Updated: 2023-02-24
Effect of tranilast on facial neuralgia
RecruitingJPRN-jRCTs061230013
Start: 2023-10-25Target: 15Updated: 2025-07-18
Effect of Kampo medicine on those who plan to receive the new COVID-19 vaccine
RecruitingJPRN-jRCTs031230190
Start: 2023-06-28Target: 40Updated: 2025-07-18
Phase 3
Prophylactic study for COVID-19 with Kampo medicines
RecruitingJPRN-jRCTs031200150
Start: 2020-11-27Target: 6000Updated: 2025-07-18
An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis.
RecruitingCTIS2022-500455-23-00
Start: 2024-12-11Target: 157Updated: 2025-11-12
Phase 4
The Comparison of Different Administration Routes of Pediatric Premedication
NCT02313337
Start: 2014-12-31End: 2015-12-31Target: 80Updated: 2014-12-10
The efficacy of elobixibat as bowel cleansing agent for bowel preparation before colonoscopy
Active, not recruitingJPRN-jRCTs041180026
Start: 2018-01-07Target: 154Updated: 2025-07-18